ASH 2017 Myeloma Roundtable: Game-Changing Treatment Tools in Myeloma

ASH 2017 Myeloma Roundtable: Game-Changing Treatment Tools in Myeloma

P2Professional

1 year
252 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Will flow be the method used for myeloma treatment in the long term? Does transplant still have a role in myeloma? Will liquid biopsies replace bone marrow biopsies? At the 2017 America Society of Hematology (ASH) annual meeting, a roundtable of esteemed myeloma experts, including Dr. Carol Ann Huff from Johns Hopkins University School of Medicine, Dr. Sagar Lonial of Emory University School of Medicine and Dr. Suzanne Lentzsch from New York Presbyterian Hospital/ Columbia University Medical Center, weigh in on the breaking news and the expansion of the treatment armamentarium in and implications for different disease status. Host Jenny Ahlstrom, President and Founder of Myeloma Crowd, moderates this discussion and summarizes through the patient lens. Watch now as the myeloma experts discuss forthcoming game-changing tools in myeloma. Get email alerts | http://www.patientpower.info/alerts Subscribe on YouTube | http://www.youtube.com/patientpower Like on Facebook | http://www.fb.com/patientpower.info Follow on Twitter | http://www.twitter.com/patientpower Follow on Google+ | http://www.google.com/+patientpowerinfo
Up Next Autoplay
ASH 2017: New Drugs and Numerous Drug Combinations in Myeloma
ASH 2017: New Drugs and Numerous Drug Combinations in Myeloma
Category: Acute Lymphoblastic Leukemia
1,300 Views
P2Professional 1 year
Treatment News in Lymphoma From ASH 2017
Treatment News in Lymphoma From ASH 2017
Category: Acute Lymphoblastic Leukemia
1,141 Views
P2Professional 1 year
Making Treatment Decisions in Myeloma: How Do I Know What’s Right for Me?
Making Treatment Decisions in Myeloma: How Do I Know What’s Right for Me?
Category: Acute Lymphoblastic Leukemia
974 Views
P2Professional 1 year
ROR1: An Update From ASH 2017
ROR1: An Update From ASH 2017
Category: Acute Lymphoblastic Leukemia
1,263 Views
P2Professional 1 year
ASH 2017: CLL Combination Therapy News
ASH 2017: CLL Combination Therapy News
Category: Acute Lymphoblastic Leukemia
1,056 Views
P2Professional 1 year
ASH 2017: Are Experts Personalizing Therapy to the Genetics of a Patient’s Myeloma?
ASH 2017: Are Experts Personalizing Therapy to the Genetics of a Patient’s Myeloma?
Category: Acute Lymphoblastic Leukemia
554 Views
P2Professional 1 year
CAR T-Cell Therapy Update From ASH 2017
CAR T-Cell Therapy Update From ASH 2017
Category: Acute Lymphoblastic Leukemia
175 Views
P2Professional 1 year
What the MPN Experts Learned at ASH 2017
What the MPN Experts Learned at ASH 2017
Category: Acute Lymphoblastic Leukemia
146 Views
P2Professional 1 year
ASH 2017: Promising Mantle Cell Lymphoma Treatment News
ASH 2017: Promising Mantle Cell Lymphoma Treatment News
Category: Acute Lymphoblastic Leukemia
404 Views
P2Professional 1 year
CAR T-Cell Therapy News From ASH 2017
CAR T-Cell Therapy News From ASH 2017
Category: Acute Lymphoblastic Leukemia
324 Views
P2Professional 1 year